Document is current
Any future updates will be listed below
-
Authors
Zhao, Erming
Liang, Rukang
Li, Panlong
Lu, Di
Chen, Shuhan
Tan, Weikeng
Qin, Yunfei
Zhang, Yana
Zhang, Yingcai
Zhang, Qi
Liu, Qiuli https://orcid.org/0000-0002-8090-8718
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (81971526 and 82370629)
the Natural Science Foundation of Guangdong Province (2022A1515012223)
the Science and Technology Program of Guangzhou (202201020398, 202201020430)
- License Information
-
More Information
Article History
Received: 18 August 2024
Accepted: 13 October 2024
First Online: 3 November 2024
Declarations
:
: The animal protocol was reviewed and approved by the Institutional Animal Care and Use Committee (IACUC), Sun Yat-Sen University (Title: Mesenchymal stem cells alleviate acute liver injury in a mouse model induced by acetaminophen; Approval number: SYSU-IACUC-2023-000849; Date: May 25, 2023). For the patients’ samples, the patients or their guardians provided written informed consent for participation in the study and the use of samples. All the human tissue experiments were approved by the Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University (Title: Role of the RNA-Editing Enzyme ADAR1 in Regulating the Immunosuppressive Function of Mesenchymal Stem Cells in the Treatment of Acute Liver Failure; Approval number: RG2023-301-02; Date: January 5, 2024).
: The materials used in this study are available in the supplementary material.
: The authors declare that they have no conflicts of interest.
